This country profile provides an overview of Burkina Faso’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
80%
Blinding trachoma
N/A
Intestinal worms
N/A
Bilharzia
83%
River blindness
82%
2.92 million
people received treatment in Burkina Faso in 2019
727k
people did not receive treatment in Burkina Faso in 2019
Elephantiasis
Treatment coverage increased from 77% in 2018 to 80% in 2019.
People needing treatment
2.11m
People receiving treatment
1.70m
Blinding trachoma
Burkina Faso is conducting post-preventive chemotherapy surveillance.
Intestinal worms
Burkina Faso does not require mass treatment for intestinal worms.
Bilharzia
Treatment coverage decreased from 100% in 2018 to 83% in 2019.
School-aged children needing treatment
2.17m
School-aged children receiving treatment
1.81m
River blindness
Treatment coverage remained at 82% in 2018 and 2019.
People needing treatment
275k
People receiving treatment
224k
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Burkina Faso.